While our multi-round tumor challenge assay did not reveal a clear enhancement of CAR-iCD8+ T cell function by CAR-iCD4+ T cells, the consistent dominance of iCD8+ T cells in the CD4/CD8 co-culture group suggests functional interplay between the two subsets (Fig. 5F, H) [10]. The gene discussed is CD8A; the disease is neoplasm.